Live tape
Top 8, mentions 7d9,857TSLA2,037 mentions▲ +0.05GOOGL1,585 mentions▲ +0.04NVDA1,207 mentions▲ +0.07CRWV1,197 mentions▲ +0.03SPCX1,070 mentions▲ +0.07QQQ1,042 mentions▲ +0.04META874 mentions▲ +0.05NBIS845 mentions▲ +0.05

Equity · Healthcare

NAMS

NASDAQ

NewAmsterdam Pharma Company N.V.

$31.67 +2.13% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for NAMS to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $3.8B
52-week range $21 – $41
Avg volume 263.6K

as of Jul 17, 2026

NAMS insider trades

SEC Form 4

NAMS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 15 September 2025.

Date Insider Type Shares Value
15 Sep 2025 Topper James N Buy 660 $16K

NAMS reported financials

SEC EDGAR XBRL SEC EDGAR

NAMS reported revenue of $22.5M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$203.8M.

Figure Reported Period
Revenue $22.5M 31 Dec 2025 fiscal year
Net income −$203.8M 31 Dec 2025 fiscal year
Diluted EPS −$1.72 31 Dec 2025 fiscal year
Total assets $704.5M 30 Jun 2026 at period end
Total equity $631.4M 30 Jun 2026 at period end

NAMS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.52 $4M
31 Mar 2026 Q1 2026 −$0.40 $3M
31 Dec 2025 FY 2025 −$1.72 $23M
30 Sep 2025 Q3 2025 −$0.61 $0M
30 Jun 2025 Q2 2025 −$0.15 $19M
31 Mar 2025 Q1 2025 −$0.34 $3M
31 Dec 2024 FY 2024 −$2.56 $46M
30 Sep 2024 Q3 2024 −$0.18 $29M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

NAMS institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a NAMS position for the quarter ended 30 Jun 2026 — a combined $412.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Viking Global Investors Held (±25%) 4,203,567 $142.5M
Maverick Capital Added +49.5% shares 3,267,802 $110.7M
Duquesne Family Office Held (±25%) 3,070,146 $104.0M
Citadel Advisors Held (±25%) −9.3% shares 645,805 $21.9M
Millennium Management Added +65.1% shares 501,614 $17.0M
Point72 Asset Management New position 168,901 $5.7M
D. E. Shaw & Co. New position 120,561 $4.1M
Man Group New position 80,832 $2.7M
Tudor Investment Corp New position 79,460 $2.7M
AQR Capital Management Added +118.5% shares 22,691 $769K

Showing the 10 largest of 11 reported positions. The figures above count all of them.

NAMS fails-to-deliver

SEC CNS data SEC

On 24 Sep 2026, 115,916 shares of NAMS failed to deliver (about $2.6M).

Settlement date Shares failed Notional % of shares out
24 Sep 2026 115,916 $2.6M 0.097%
22 Sep 2026 1,866 $42K 0.002%
18 Sep 2026 2,763 $61K 0.002%
17 Sep 2026 32 $678 <0.001%
09 Sep 2026 10,021 $257K 0.008%
04 Sep 2026 2,393 $62K 0.002%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings